1
|
Martínez-Laperche C, Sanz-Villanueva L, Díaz Crespo FJ, Muñiz P, Martín Rojas R, Carbonell D, Chicano M, Suárez-González J, Menárguez J, Kwon M, Diez Martín JL, Buño I, Bastos Oreiro M. Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment. BMC Cancer 2022; 22:1224. [PMID: 36443715 PMCID: PMC9703722 DOI: 10.1186/s12885-022-10335-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Affiliation(s)
- C. Martínez-Laperche
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Department of Hematology, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), C/ Doctor Esuerdo 46, 28007 Madrid, Spain
| | - L. Sanz-Villanueva
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Department of Hematology, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), C/ Doctor Esuerdo 46, 28007 Madrid, Spain
| | - F. J. Díaz Crespo
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Pathology Department, Gregorio Maranon General University Hospital, Madrid, Spain
| | - P. Muñiz
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Department of Hematology, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), C/ Doctor Esuerdo 46, 28007 Madrid, Spain
| | - R. Martín Rojas
- grid.410526.40000 0001 0277 7938Department of Hematology, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), C/ Doctor Esuerdo 46, 28007 Madrid, Spain
| | - D. Carbonell
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Department of Hematology, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), C/ Doctor Esuerdo 46, 28007 Madrid, Spain
| | - M. Chicano
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Department of Hematology, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), C/ Doctor Esuerdo 46, 28007 Madrid, Spain
| | - J. Suárez-González
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Genomics Unit, Gregorio Maranon General University Hospital, IiSGM, Madrid, Spain
| | - J. Menárguez
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Pathology Department, Gregorio Maranon General University Hospital, Madrid, Spain
| | - M. Kwon
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Department of Hematology, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), C/ Doctor Esuerdo 46, 28007 Madrid, Spain
| | - J. L. Diez Martín
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Department of Hematology, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), C/ Doctor Esuerdo 46, 28007 Madrid, Spain ,grid.4795.f0000 0001 2157 7667Department of Medicine, School of Medicine, Complutense University of Madrid, Madrid, Spain
| | - I. Buño
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Department of Hematology, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), C/ Doctor Esuerdo 46, 28007 Madrid, Spain ,grid.410526.40000 0001 0277 7938Genomics Unit, Gregorio Maranon General University Hospital, IiSGM, Madrid, Spain ,grid.4795.f0000 0001 2157 7667Department of Cellular Biology, School of Medicine, Complutense University of Madrid, Madrid, Spain
| | - M. Bastos Oreiro
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Department of Hematology, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), C/ Doctor Esuerdo 46, 28007 Madrid, Spain
| |
Collapse
|
2
|
Martínez-Laperche C, Sanz-Villanueva L, Díaz Crespo FJ, Muñiz P, Martín Rojas R, Carbonell D, Chicano M, Suárez-González J, Menárguez J, Kwon M, Diez Martín JL, Buño I, Bastos Oreiro M. EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment. BMC Cancer 2022; 22:982. [PMID: 36104682 PMCID: PMC9476261 DOI: 10.1186/s12885-022-10070-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2022] [Accepted: 08/05/2022] [Indexed: 11/10/2022] Open
Abstract
AbstractEZH2 is mutated in nearly 25% of follicular lymphoma (FL) cases. Little is known about how EZH2 affects patients’ response to therapy. In this context, the aim of this study was to retrospectively analyze the frequency of mutations in EZH2 at diagnosis in tissue and ctDNA in patients with FL and to assess the patients’ outcomes after receiving immunochemotherapy, depending on the EZH2 mutation status. Among the 154 patients included in the study, 27% had mutated EZH2 (46% with high-grade and 26% with low-grade FL). Of the mutated tissue samples, the mutation in ctDNA was identified in 44% of cases. EZH2 mutation in ctDNA was not identified in any patient unmutated in the tissue.Unmutated patients who received R-CHOP had significantly more relapses than patients who received R-Bendamustine (16/49 vs. 2/23, p = 0.040). Furthermore, our results show that patients with mutated EZH2 treated with R-CHOP vs. those treated with R-Bendamustine present a lower incidence of relapse (10% vs. 42% p = 0.09 at 4 years), a higher PFS (92% vs. 40% p = 0.039 at 4 years), and higher OS (100% vs. 78% p = 0.039 at 4 years). Based on these data, RCHOP could be a more suitable regimen for mutated patients, and R-bendamustine for unmutated patients. These findings could mean the first-time identification of a useful biomarker to guide upfront therapy in FL.
Collapse
|
3
|
Sanz‐Villanueva L, Díaz Crespo F, Martín Rojas R, Carbonell D, Chicano M, Suárez‐González J, Muñiz P, Menárguez J, Kwon M, Diez Martín JL, Buño I, Martínez‐Laperche C, Bastos Oreiro M. ANALYSIS OF
EZH2
MUTATIONS IN SOLID AND LIQUID BIOPSY AND ITS ROLE AS PREDICTIVE BIOMARKER FOR CHEMOTHERAPY IN PATIENTS WITH FOLLICULAR LYMPHOMA. Hematol Oncol 2021. [DOI: 10.1002/hon.38_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- L. Sanz‐Villanueva
- Gregorio Marañón Health Research Institute (IiSGM) Gregorio Marañón General University Hospital Department of Hematology Madrid Spain
| | - F. Díaz Crespo
- Gregorio Marañón Gregorio Marañón General University Hospital Pathology Department Madrid Spain
| | - R. Martín Rojas
- Gregorio Marañón General University Hospital Department of Hematology Madrid Spain
| | - D. Carbonell
- Gregorio Marañón Health Research Institute (IiSGM) Gregorio Marañón General University Hospital Department of Hematology Madrid Spain
| | - M. Chicano
- Gregorio Marañón Health Research Institute (IiSGM) Gregorio Marañón General University Hospital Department of Hematology Madrid Spain
| | - J. Suárez‐González
- Gregorio Marañón Health Research Institute (IiSGM) Gregorio Marañón General University Hospital Genomics Unit Madrid Spain
| | - P. Muñiz
- Gregorio Marañón Health Research Institute (IiSGM) Gregorio Marañón General University Hospital Department of Hematology Madrid Spain
| | - J. Menárguez
- Gregorio Marañón General University Hospital Department of Hematology and Pathology Madrid Spain
| | - M. Kwon
- Gregorio Marañón Health Research Institute (IiSGM) Gregorio Marañón General University Hospital Department of Hematology Madrid Spain
| | - J. L. Diez Martín
- Gregorio Marañón Health Research Institute (IiSGM) Gregorio Marañón General University Hospital Department of Hematology Complutense University of Madrid, Department of Medicine Madrid Spain
| | - I. Buño
- Gregorio Marañón Health Research Institute (IiSGM) Gregorio Marañón General University Hospital Department of Hematology and Genomics Unit Complutense University of Madrid Department of Cellular Biology Madrid Spain
| | - C. Martínez‐Laperche
- Gregorio Marañón Health Research Institute (IiSGM) Gregorio Marañón General University Hospital Department of Hematology Madrid Spain
| | - M. Bastos Oreiro
- Gregorio Marañón Health Research Institute (IiSGM) Gregorio Marañón General University Hospital Department of Hematology Madrid Spain
| |
Collapse
|